Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Wendy Osborne

Academic history

Dr Wendy Osborne is a Consultant Haematologist at the Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust. She graduated with First Class Honours from Newcastle University in 1998 and completed her General Medical Training at Queens Medical Centre, Nottingham. Dr Osborne worked in haematology departments in Glasgow before returning to Newcastle to undertake Higher Specialist Training.

Dr Osborne is Chair of the British Society of Haematology Lymphoma Special Interest Group and a member of the NCRI Clinical Studies Group, High Grade lymphoma sub-group, Hodgkin lymphoma subgroup. Dr Osborne is on the medical advisory panel for Lymphoma Action and is a principal investigator and co-investigator for numerous clinical trials. Dr Osborne is an Honorary Clinical Senior Lecturer at Newcastle University and teaching lead for the haematology undergraduate programme.

Speaking on myeloproliferative disorders

Dr Osborne’s work has ranged from studying myeloproliferative disorders and the management of hematological malignancies in older populations to, more recently, investigating chimeric antigen receptor (CAR) T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Dr Osborne’s team developed the first bicistronic CAR T-cell therapy targeting CD19 and CD22.